| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/20/1992 | CA2054555A1 Nitrogen compounds |
| 05/15/1992 | WO1992008481A1 Stabilized, potent grf analogs |
| 05/15/1992 | CA2092906A1 Stabilized, potent grf analogs |
| 05/14/1992 | WO1992007831A1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 05/05/1992 | CA1300018C Antigestagens for shifting the endometrial maturation |
| 04/28/1992 | CA1299507C Grf analogs |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/21/1992 | CA1299169C Steroids having a spiro cycle in position 17, their process and intermediaries,their use as medications and the pharmaceutical preparations containing such |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/13/1992 | CA2050046A1 Peptide and diagnostic for diseases with abnormal thyroid functions comprising the same |
| 04/01/1992 | EP0477885A2 Parathyroid hormone derivatives |
| 04/01/1992 | EP0477499A1 Gonadoliberin antagonists |
| 03/31/1992 | CA1298433C Amino acid derivatives |
| 03/24/1992 | US5098995 GRF Analogs VIIA |
| 03/18/1992 | EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP) |
| 03/18/1992 | EP0475290A1 A novel biologically active peptide derived from frog (frog CNP) |
| 03/18/1992 | CN1059517A Acetamide derivatives |
| 03/17/1992 | CA1297472C 11-aryloestrane and 11-arylpregnane derivatives |
| 03/11/1992 | EP0474008A1 Amino acid derivatives |
| 03/11/1992 | EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 03/10/1992 | US5095129 Antiglucocorticoid, antimineralcorticoid, antiandrogen |
| 03/04/1992 | EP0473252A2 Use of L-deprenyl for retarding deterioration due to aging in dogs |
| 03/04/1992 | CN1059150A Steroids and their use as 5 alpha-reductase inhibitors |
| 03/03/1992 | US5093507 Estrenes, antiglucocorticoid, antiestrogen |
| 03/01/1992 | CA2050092A1 Amino acid derivatives |
| 02/26/1992 | EP0472033A2 3,5-Diiod-L-thyronin for TSH-suppression and the treatment of goiter |
| 02/25/1992 | US5091367 Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 02/25/1992 | CA1296486C Therapeutic peptides |
| 02/19/1992 | EP0471612A2 New steroids having an amide substituted group in the 11-beta position, their preparation, their use as medicines and pharmaceutical composition thereof |
| 02/19/1992 | CN1058779A Carbostyril derivatives and pharmaceutical composition containing the same |
| 02/18/1992 | US5089488 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same |
| 02/15/1992 | CA2049102A1 19-nor-steroids with a carbon chain in 11-beta containing an amido group, preparation thereof, their application as drugs and pharmaceutical compositions containing them |
| 02/12/1992 | EP0470514A1 Carbostyril derivatives and pharmaceutical composition containing the same |
| 02/05/1992 | EP0469887A1 Acetamide derivatives |
| 02/05/1992 | EP0469547A2 4-Amino-delta4,6-steroids and their use as 5alpha-reductase inhibitors |
| 02/04/1992 | US5086047 Controlling estrogen production; breast cancer |
| 02/03/1992 | CA2048325A1 Acetamide derivatives |
| 01/29/1992 | EP0468042A1 HOMOLOGATED VITAMIN D 2? COMPOUNDS AND THE CORRESPONDING 1-g(a)-HYDROXYLATED DERIVATIVES. |
| 01/25/1992 | WO1992001711A1 Polypeptide compounds having growth hormone releasing activity |
| 01/25/1992 | CA2086928A1 Polypeptide compounds having growth hormone releasing activity |
| 01/21/1992 | CA1294737C Cck antagonists |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | CN1057843A Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents |
| 01/15/1992 | CN1057842A Bis(4-(2,6-di-alkyl) phenol) silane derivatives as antiathe-rosclerotic agents |
| 01/09/1992 | WO1992000010A1 Method of treating human prostatic adenocarcinoma |
| 01/08/1992 | EP0464852A1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants |
| 01/08/1992 | EP0464844A1 Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants |
| 01/08/1992 | EP0464549A1 Calcitonin analogues and use thereof |
| 12/27/1991 | EP0462662A2 17beta-N-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones |
| 12/21/1991 | CA2058920A1 17.beta.-n-monosubstituted adamantyl/carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones and androstan-3-ones as 5.alpha.-reductase |
| 12/17/1991 | US5073574 Tetrazolyl substituted benzonitriles and anti-tumor use thereof |
| 12/17/1991 | US5073566 Angiotensin ii antagonist 1,3-imidazoles and use thereas |
| 12/17/1991 | US5073548 Antiprogestational, progestational and antiglucocorticoid activity; glandular disorders; vision defects; antifertility agents |
| 12/12/1991 | WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth |
| 12/12/1991 | WO1991018570A1 Therapeutically effective topical application of st1435 |
| 12/12/1991 | WO1991001958A3 11β-ARYL-GONA-4,9-DIEN-3-ONES |
| 12/10/1991 | US5071836 Competitive gonadoliberin antagonists |
| 12/07/1991 | WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
| 12/04/1991 | EP0459747A1 Precursor forms of porcine growth hormone releasing factor and related DNA compounds |
| 11/30/1991 | CA2043049A1 Precursor forms of procine growth hormone releasing factor and related dna compounds |
| 11/28/1991 | WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan |
| 11/26/1991 | US5068222 Polypeptides for treatment of cancer |
| 11/13/1991 | EP0455805A1 A method of stimulating steroidogenesis with alpidem |
| 11/06/1991 | CN1055925A Pyridine derivatives |
| 11/05/1991 | WO1991016923A1 Novel synthetic grf analogs |
| 11/05/1991 | CA2082059A1 Synthetic grf analogs |
| 10/30/1991 | EP0438519A4 Therapeutic peptides |
| 10/29/1991 | US5061690 Administering human growth regulating hormone during pregnancy |
| 10/29/1991 | US5061493 Galenical forms of corticoids for administration perlingually and sublingually and process for their preparation |
| 10/23/1991 | EP0453210A2 Pyridine derivatives |
| 10/20/1991 | CA2040747A1 Pyridine derivatives |
| 10/16/1991 | CN1055365A Haloethyl-substituted steroidal enzyme inhibitors |
| 10/15/1991 | US5057521 Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
| 10/15/1991 | US5057496 Dipeptide compounds containing histidine or n-methyl histidine processes for their preparation and compositions containing them |
| 10/09/1991 | EP0450515A2 Haloethyl-substituted steroidal enzyme inhibitors |
| 10/01/1991 | CA1289944C 11 .beta.-(4-ISOPREPENYLPHENYL)ESTRA-4,9-DIENES, THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| 09/24/1991 | US5051445 3-amino-propyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them |
| 09/19/1991 | WO1991004058A3 Treatment of conditions and disease |
| 09/11/1991 | EP0446062A1 C-Linked pyrazole derivatives |
| 09/11/1991 | EP0381747A4 Water soluble branched beta cyclodextrin steroid complex |
| 09/10/1991 | US5047564 Fluorine-containing vitamin D2 derivatives |
| 09/10/1991 | CA2037872A1 C-linked pyrazole derivatives |
| 09/10/1991 | CA1288695C Method for increasing bone mass |
| 09/05/1991 | WO1991013092A1 Vasoactive vasotocin derivatives |
| 09/05/1991 | WO1991013083A1 Steroid sulphatase inhibitors |
| 09/05/1991 | WO1991013060A1 Indole derivatives |
| 09/05/1991 | WO1991012799A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
| 09/04/1991 | CN1054250A 吲哚衍生物 Indole derivatives |
| 08/29/1991 | WO1991012800A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
| 08/27/1991 | US5043331 Kit; uninterrupted oral daily dose of estrogen and progestogen compounds for 90 day period; prevents endometrial hyperplasiz and osteoporosis |
| 08/27/1991 | US5043322 Cyclic GRF analogs |
| 08/27/1991 | CA1288195C Gnrh antagonists ix |
| 08/22/1991 | WO1991012239A1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1α-HYDROXYLATED DERIVATIVES |
| 08/13/1991 | CA1287577C Growth promoting compositions |
| 08/08/1991 | WO1991011457A1 Glp-1 analogs useful for diabetes treatment |
| 08/07/1991 | EP0439797A1 Antibodies specifically recognizing somatotropin binding protein |
| 08/06/1991 | US5037817 Crystallization from polar or apolar solvents; produces two crystalline pure forms; improved stability increases shelf-life |
| 08/01/1991 | CA2035200A1 Antibodies specifically recognizing somatotropin binding protein |
| 07/31/1991 | EP0438869A1 Improvements in and relating to angiotensin II antagonists |
| 07/31/1991 | EP0438519A1 Therapeutic peptides |